Pui W. Cheung

ORCID: 0000-0001-6615-3761
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ion Transport and Channel Regulation
  • Electrolyte and hormonal disorders
  • Renal and related cancers
  • Ion channel regulation and function
  • Neonatal Respiratory Health Research
  • Hormonal Regulation and Hypertension
  • Intensive Care Unit Cognitive Disorders
  • Urinary Bladder and Prostate Research
  • Estrogen and related hormone effects
  • Magnesium in Health and Disease
  • Prostate Cancer Treatment and Research
  • Neurological and metabolic disorders
  • Restraint-Related Deaths
  • Systemic Lupus Erythematosus Research
  • Erythrocyte Function and Pathophysiology
  • Autoimmune Neurological Disorders and Treatments
  • Pancreatic function and diabetes
  • Child Abuse and Related Trauma
  • Poisoning and overdose treatments
  • Pharmaceutical Practices and Patient Outcomes
  • ATP Synthase and ATPases Research
  • Vitamin K Research Studies
  • Lymphoma Diagnosis and Treatment
  • Hormonal and reproductive studies
  • Acute Kidney Injury Research

Massachusetts General Hospital
2015-2024

Harvard University
2016-2024

University of North Carolina at Chapel Hill
2024

Duke University
2024

Center for Systems Biology
2016-2019

MGH Institute of Health Professions
2017

University of Pittsburgh
2014

National Center for Complementary and Integrative Health
2008

National Institutes of Health
2008

BackgroundIn clinical practice, sodium correction rates are frequently limited in patients with severe hyponatremia to prevent neurologic complications. The implications of on overall mortality and length hospital stay unclear.MethodsIn this multicenter observational study, we evaluated the association mortality, stay, central pontine myelinolysis (CPM) hospitalized (admission serum level less than 120 mEq/l).ResultsThe cohort included 3274 patients. A rate 6 mEq/l/24 hours was observed 38%,...

10.1056/evidoa2300107 article EN NEJM Evidence 2023-09-26

Nephrogenic diabetes insipidus (NDI) is caused by impairment of vasopressin (VP) receptor type 2 signaling. Because potential therapies for NDI that target the canonical VP/cAMP/protein kinase A pathway have so far proven ineffective, alternative strategies modulating aquaporin (AQP2) trafficking been sought. Successful identification compounds our high–throughput chemical screening assay prompted us to determine whether EGF (EGFR) inhibitors stimulate AQP2 and reduce urine output....

10.1681/asn.2015080903 article EN Journal of the American Society of Nephrology 2016-03-09

Aquaporin 2 (AQP2) trafficking is regulated by phosphorylation and dephosphorylation of serine residues in the AQP2 COOH terminus. Vasopressin (VP) binding to its receptor (V2R) leads a cascade events that result 256 (S256), S264, S269, but S261. To identify which phosphatase responsible for VP-induced S261 dephosphorylation, we pretreated cells with different inhibitors before VP stimulation. Sanguinarine, specific protein (PP) 2C inhibitor, not PP1, PP2A (okadaic acid), or PP2B...

10.1152/ajprenal.00004.2017 article EN AJP Renal Physiology 2017-04-06

Key points Aquaporin‐2 (AQP2) is crucial for water homeostasis, and vasopressin (VP) induces AQP2 membrane trafficking by increasing intracellular cAMP, activating PKA causing phosphorylation of at serine 256, 264 269 residues dephosphorylation 261 residue on the C‐terminus. It thought that 256 master regulator trafficking, its has to precede change state other residues. We found Src inhibition causes 256‐independent independently 256. This targeted important inhibition‐induced accumulation;...

10.1113/jp277024 article EN The Journal of Physiology 2018-11-29

We previously showed that in polarized Madin–Darby canine kidney (MDCK) cells, aquaporin-2 (AQP2) is continuously targeted to the basolateral plasma membrane from which it rapidly retrieved by clathrin-mediated endocytosis. It then undertakes microtubule-dependent transcytosis toward apical membrane. In this study, we found treatment with chlorpromazine (CPZ, an inhibitor of endocytosis) results AQP2 accumulation basolateral, but not epithelial cells. MDCK both and clathrin were concentrated...

10.3390/cells9041057 article EN cc-by Cells 2020-04-23

Aquaporin-2 (AQP2) undergoes constitutive recycling between the cytoplasm and plasma membrane, with an intricate balance endocytosis exocytosis. By inhibiting actin-related protein (Arp)2/3 complex, we prevented AQP2 from entering exocytotic pathway at post- trans-Golgi network level blocked membrane accumulation. Arp2/3 inhibition, therefore, enables us to separate target process, while not affecting endocytosis, thus allowing envisage strategies modulate trafficking treat water disorders.

10.1152/ajprenal.00015.2021 article EN AJP Renal Physiology 2021-06-28

A 79-year-old man was admitted to this hospital because of hyponatremia and involuntary movements, which would start in the left arm hand then involve side face, such that he look as though grimacing. After received treatment for hyponatremia, movements worsened. diagnosis made.

10.1056/nejmcpc1913477 article EN New England Journal of Medicine 2020-05-13

Vasopressin (VP)-regulated aquaporin-2 (AQP2) trafficking between cytoplasmic vesicles and the plasma membrane of kidney principal cells is essential for water homeostasis. VP affects AQP2 phosphorylation at several serine residues in COOH-terminus; among them, 256 (S256) appears to be a major regulator trafficking. Mutation this aspartic acid, which mimics phosphorylation, induces constitutive expression AQP2. However, intracellular location(s) S256 occurs remains elusive. Here, we used...

10.1152/ajprenal.00123.2022 article EN AJP Renal Physiology 2022-12-01

Oxidative stress affects a wide variety of cellular processes including morphology, protein traffcking, and cell death. Several studies show that reactive oxygen species (ROS) are able to pass through some water channels, ROS may modulate aquaporin expression traffcking. However, relationship between status the traffcking aquaporin-2 (AQP2) has yet be well-defined. To address this question, we first treated LLC-PK1 cells expressing cmyc-tagged AQP2 (LLC-AQP2 cells) for 30 min with menadione...

10.1152/physiol.2024.39.s1.1636 article EN Physiology 2024-05-01

In the canonical aquaporin-2 (AQP2) signaling pathway, vasopressin (VP) binds to its V2 receptor, which in turn activates adenylate cyclase and protein kinase A (PKA), resulting AQP2 S256 phosphorylation accumulation of membrane. The epidermal growth factor receptor (EGFR) inhibitor erlotinib also increases membrane accumulation, yet it does not increase cAMP or PKA activity. We hypothesize that ribosomal s6 (RSK), a downstream effector EGFR-MAPK/ERK is terminal phosphorylating this novel...

10.1152/physiol.2024.39.s1.1486 article EN Physiology 2024-05-01

The cAMP‐sensitive water channel (AQP2) plays an important role in regulation the renal collecting ducts. Upon stimulation by vasopressin (VP), AQP2 is phosphorylated at c‐terminus on serine 256 (pS256). This event leads to accumulation plasma membrane. Other residues including S264 and S269 are also phosphorylated, but phosphorylation of S256 thought be essential membrane accumulation, has precede other residues. Here we show that inhibiting proto‐oncogene tyrosine‐protein kinase Src using...

10.1096/fasebj.31.1_supplement.855.18 article EN The FASEB Journal 2017-04-01

Impairment of vasopressin (VP) receptor type 2 (V2R) signaling in the kidney is detrimental to water homeostasis. However, strategies targeting cAMP treat diseases associated with balance have so far been unsuccessful humans, prompting a search for alternative pathways that modulate AQP2 trafficking. Our previous study using high-throughput small molecule screening showed AG-490, an EGFR and JAK-2 kinase inhibitor, enhanced membrane expression. Therefore, we tested erlotinib (ERL),...

10.1096/fasebj.29.1_supplement.809.16 article EN The FASEB Journal 2015-04-01

Aquaporin‐2 (AQP2), the vasopressin (VP)‐sensitive water channel, plays an important role in reabsorption. Accumulation of AQP2 on plasma membrane kidney collecting duct principal cells increases permeability and is necessary for urine concentration. trafficking tightly regulated by phosphorylation dephosphorylation, each four phosphoserine residues (pS256, pS261, pS264 pS269) has been intensively studied. Recent work our laboratory shown that erlotinib (Erl), epidermal growth factor...

10.1096/fasebj.30.1_supplement.lb764 article EN The FASEB Journal 2016-04-01

Intercalated cells (IC) in kidney collecting ducts are essential for acid‐base homeostasis. A proteomic analysis of these after purification by FACS revealed unexpectedly that they express high levels neprilysin, a neutral protease, previously reported to be located the brush border proximal tubule cells. Therefore, we re‐examined distribution neprilysin immunohistochemistry and western blot analysis. Using anti‐neprilysin antibodies two duct markers: anti‐AQP2 antibody (principal cells)...

10.1096/fasebj.2019.33.1_supplement.544.13 article EN The FASEB Journal 2019-04-01

Aquaporin 2 (AQP2) is a water channel protein located primarily on principal cells of kidney collecting ducts, and crucial for regulating body homeostasis. Regulation AQP2 trafficking subject to hormonal control, mainly via the canonical vasopressin (VP) signaling pathway which stimulates membrane accumulation. Active actin cytoskeleton remodeling also plays an important role in trafficking, but mechanism incompletely understood. Using immunohistochemistry confocal microscopy, we discovered...

10.1096/fasebj.2020.34.s1.09019 article EN The FASEB Journal 2020-04-01

Abstract Vasopressin (VP) activates PKA, resulting in phosphorylation and membrane accumulation of aquaporin-2 (AQP2). Epidermal growth factor receptor (EGFR) inhibition with erlotinib also induces AQP2 trafficking a pattern similar to VP, but without increasing PKA activity. Here, we identify the ribosomal s6 kinase (RSK) as final mediator phosphorylating this novel, erlotinib-induced pathway. We found that RSK was expressed medullary principal cells rat kidneys. BI-D1870 or siRNA blocked...

10.1101/2022.12.06.519384 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2022-12-10
Coming Soon ...